| VANDA PHARMACEUTICALS |
| USA |
| Gesundheit |
| US9216591084 / A0JJT3 |
| VM4 (Frankfurt) / VNDA (NASDAQ) |
| FRA:VM4, ETR:VM4, VM4:GR, NASDAQ:VNDA |
| - |
| https://www.vandapharma.c.. |
|
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapies addressing high unmet medical needs in areas such as sleep-wake disorders, psychiatric and neurologic conditions, motion sickness,..
>Volltext.. |
| 278.51 Mio. EUR |
| 149.55 Mio. EUR |
| 184.7 Mio. EUR |
| -146 Mio. EUR |
| -235.32 Mio. EUR |
| -3.96 EUR |
| 19.55 Mio. EUR |
| 47.93 Mio. EUR |
| -121.86 Mio. EUR |
| 1.04 |
| 9.36% |
| -323.53% |
| - |
| - |
| - |
| - |
| VANDA |
| 23.08.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|